Attempts by Oxford University researchers and AstraZeneca Plc. to create a nasal-spray version of their jointly developed COVID-19 shot suffered a setback on Tuesday as initial testing on humans did not yield the desired protection. An antibody response in the respiratory mucous membranes was seen in only a minority of participants in the trial, which…